The Access to Medicine Index is a very important project. What gets measured, gets done.
Worldwide, preventable diseases still cost millions of lives each year. The Access to Vaccines Index will reveal how eight key vaccine companies are improving access to vaccines for 69 diseases in 107 countries. It analyses company practice in three areas:
- Research & Development
- Pricing & Registration
- Manufacturing & Supply
News and Events
14 Feb 2017
13 Dec 2016
29 Nov 2016
08 Nov 2016
20 Sep 2016
Positions in Research, Finance, Strategy
Interested in working toward the next Access to Medicine Index or on our new AMR Benchmark? Or in joining the Foundation’s Finance and Strategy teams?
Access to medicine: a material issue for investors
Investors engage with the Foundation for insight into our analysis of the pharma sector, including into governance structures, R&D and pricing strategies.
The foundation on Twitter
“To improve access, we believe pharmaceutical companies need to focus on how
they deploy their products, and, as global citizens, collaborate on the development of strong health systems.”
Jayasree K. Iyer, Executive Director, Access to Medicine Foundation.
The Access to Medicine Foundation and its publications are funded by